Variable | Total (n = 169) | Intervention group (n = 84) | Control group (n = 85) |
---|---|---|---|
Age mean (SD), years | 40.7 (9.8) | 40.6 (9.4) | 40.7 (10.2) |
Gender, N (%) | |||
- Male | 127 (75.1) | 61 (72.6) | 66 (77.6) |
Patients > 50% medication adherence, N (%) | 135 (79.9) | 68 (80.0) | 67 (79.8) |
Place of treatment, N (%) | |||
- The Hague | 46 (27.2) | 18 (21.4) | 18 (21.2) |
- Rotterdam | 123 (72.8) | 66 (78.6) | 67 (78.8) |
Substance use disorder, N (%) | 94 (55.6) | 48 (57.1) | 46 (54.1) |
Antipsychotic Medication side effects, mean (SD) | 4,8 (4,0) | 5,3 (4,0) | 4,3 (3,9) |
Illness insight; median (interquartile range) (range 1–7) | 3 (1–4) | 3 (1–4) | 2 (1–4) |
Health of the Nation Outcome Scales (HoNOS), N (%) | |||
- No motivational problems | 136 (80.4) | 66 (78.6) | 70 (82.3) |
- Severe motivational problems | 28 (16.6) | 17 (20.2) | 11 (12.9) |
- Item missing | 5 (3.0) | 1 (1.2) | 4 (4.8) |
Treatment Entry Questionnaire, (TEQ) N (%) | 85 (50.3) | 42 (50.0) | 43 (50.6) |
- External motivation; mean (SD), (range 12–84) | 18.4 (7.8) | 17.6 (8.1) | 19.0 (7.6) |
- Introjected motivation; mean (SD), (range 6–42) | 18.7 (10.6) | 19.3 (9.4) | 18.2 (9.4) |
- Identified motivation; mean (SD), (range 9–63) | 28.5 (10.0) | 28.6 (10.9) | 28.5 (9.2) |